The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer

por Claessens, Anouk K. M., Timman, Reinier, Busschbach, Jan J., Bouma, Jeanette M., Rademaker-Lakhai, Jeany M., Erdkamp, Frans L. G., Tjan-Heijnen, Vivianne C. G., Bos, Monique E. M. M.
Publicado 2019

Four-year effects of exercise on fatigue and physical activity in patients with cancer

por Witlox, Lenja, Hiensch, Anouk E., Velthuis, Miranda J., Steins Bisschop, Charlotte N., Los, Maartje, Erdkamp, Frans L. G., Bloemendal, Haiko J., Verhaar, Marlies, ten Bokkel Huinink, Daan, van der Wall, Elsken, Peeters, Petra H. M., May, Anne M.
Publicado 2018

The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2− advanced breast cancer patients: A study of the Dutch SONABRE Registry

por Meegdes, Marissa, Geurts, Sandra M. E., Erdkamp, Frans L. G., Dercksen, Marcus Wouter, Vriens, Birgit E. P. J., Aaldering, Kirsten N. A., Pepels, Manon J. A. E., van de Winkel, Linda M. H., Teeuwen, Nathalie J. A., de Boer, Maaike, Tjan‐Heijnen, Vivianne C. G.
Publicado 2021

A phase 1 ‘window-of-opportunity’ trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal ad...

por Larue, Ruben T. H. M., Van De Voorde, Lien, Berbée, Maaike, van Elmpt, Wouter J. C., Dubois, Ludwig J., Panth, Kranthi M., Peeters, Sarah G. J. A., Claessens, Ann, Schreurs, Wendy M. J., Nap, Marius, Warmerdam, Fabiënne A. R. M., Erdkamp, Frans L. G., Sosef, Meindert N., Lambin, Philippe
Publicado 2016

Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial

por Tjan-Heijnen, Vivianne C.G., Lammers, Senna W.M., Geurts, Sandra M.E., Vriens, Ingeborg J.H., Swinkels, Astrid C.P., Smorenburg, Carolien H., van der Sangen, Maurice J.C., Kroep, Judith R., de Graaf, Hiltje, Honkoop, Aafke H., Erdkamp, Frans L.G., de Roos, Wilfred K., Linn, Sabine C., Imholz, Alexander L.T.
Publicado 2023

The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer

por Lammers, Senna W M, Geurts, Sandra M E, van Hellemond, Irene E G, Swinkels, Astrid C P, Smorenburg, Carolien H, van der Sangen, Maurice J C, Kroep, Judith R, de Graaf, Hiltje, Honkoop, Aafke H, Erdkamp, Frans L G, de Roos, Wilfred K, Linn, Sabine C, Imholz, Alexander L T, Smidt, Marjolein L, Vriens, Ingeborg J H, Tjan-Heijnen, Vivianne C G
Publicado 2023

Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study

por van Hellemond, Irene E.G., Smorenburg, Carolien H., Peer, Petronella G.M., Swinkels, Astrid C.P., Seynaeve, Caroline M., van der Sangen, Maurice J.C., Kroep, Judith R., de Graaf, Hiltje, Honkoop, Aafke H., Erdkamp, Frans L.G., van den Berkmortel, Franchette W.P.J., de Boer, Maaike, de Roos, Wilfred K., Linn, Sabine C., Imholz, Alexander L.T., Tjan‐Heijnen, Vivianne C.G.
Publicado 2019

Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial

por Kurk, Sophie A., Peeters, Petra H. M., Dorresteijn, Bram, de Jong, Pim A., Jourdan, Marion, Creemers, Geert‐Jan M., Erdkamp, Frans L. G., de Jongh, Felix E., Kint, Peter A. M., Poppema, Boelo J., Radema, Sandra A., Simkens, Lieke H. J., Tanis, Bea C., Tjin‐A‐Ton, Manuel L. R., Van Der Velden, Ankie, Punt, Cornelis J. A., Koopman, Miriam, May, Anne M.
Publicado 2019

Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial

por van Hellemond, Irene E. G., Smorenburg, Carolien H., Peer, Petronella G. M., Swinkels, Astrid C. P., Seynaeve, Caroline M., van der Sangen, Maurice J. C., Kroep, Judith R., de Graaf, Hiltje, Honkoop, Aafke H., Erdkamp, Frans L. G., van den Berkmortel, Franchette W. P. J., de Roos, Wilfred K., Linn, Sabine C., Imholz, Alexander L. T., de Boer, Maaike, Tjan-Heijnen, Vivianne C. G.
Publicado 2020

Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy‐induced ovarian function failure

por van Hellemond, Irene E.G., Vriens, Ingeborg J.H., Peer, Petronella G.M., Swinkels, Astrid C.P., Smorenburg, Carolien H., Seynaeve, Caroline M., van der Sangen, Maurice J.C., Kroep, Judith R., de Graaf, Hiltje, Honkoop, Aafke H., Erdkamp, Frans L.G., van den Berkmortel, Franchette W.P.J., de Boer, Maaike, de Roos, Wilfred K., Linn, Sabine C., Imholz, Alexander L.T., Tjan‐Heijnen, Vivianne C.G.
Publicado 2019

Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry

por Meegdes, Marissa, Geurts, Sandra M.E., Erdkamp, Frans L.G., Dercksen, M. Wouter, Vriens, Birgit E.P.J., Aaldering, Kirsten N.A., Pepels, Manon J.A.E., van de Winkel, Linda M.H., Peters, Natascha A.J.B., Tol, Jolien, Heijns, Joan B., van de Wouw, Agnes J., de Fallois, Aude J.O., van Kats, Maartje A.C.E., Tjan-Heijnen, Vivianne C.G.
Publicado 2023

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry

por Meegdes, Marissa, Ibragimova, Khava I. E., Lobbezoo, Dorien J. A., Vriens, Ingeborg J. H., Kooreman, Loes F. S., Erdkamp, Frans L. G., Dercksen, M. Wouter, Vriens, Birgit E. P. J., Aaldering, Kirsten N. A., Pepels, Manon J. A. E., van de Winkel, Linda M. H., Tol, Jolien, Heijns, Joan B., van de Wouw, Agnes J., Peters, Natascha A. J. B., Hochstenbach-Waelen, Ananda, Smidt, Marjolein L., Geurts, Sandra M. E., Tjan-Heijnen, Vivianne C. G.
Publicado 2022